Older News Items

28th-January-2021

Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Pro

26th-January-2021

Hydrogen sulfide is neuroprotective in Alzheimers disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylatio

11th-January-2021

Chronic unpredictable stress induces depression-related behaviors by suppressing AgRP neuron activity

11th-January-2021

Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease

11th-January-2021

Characterizing vulnerability of selective neurons in Alzheimers

11th-January-2021

Characterizing vulnerability of selective neurons in Alzheimers

8th-January-2021

Inhibition of select mitochondrial proteins and the effect on Alzheimer’s disease

6th-January-2021

Molecular subtyping of Alzheimers disease using RNA sequencing data reveals novel mechanisms and targets

21st-December-2020

Transcriptomic organization of the human brain in post-traumatic stress disorder

13th-December-2020

New blood test reveals mBDNF lower in people with depression or bipolar disorder than in healthy controls

24th-November-2020

Multi-Omic Analysis Reveals Possible Treatment for Late-Onset Alzheimer Disease

18th-November-2020

Genetic link to molecular events that precede symptoms in Alzheimer disease

4th-November-2020

Two doses of the psychedelic substance psilocybin produce rapid and large reductions in depressive symptoms

12th-October-2020

Vascular Function, Tau, and Alzheimers

9th-October-2020

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy